Blackstone Labs | BSL SST-1 IGF/GH | 180 Tablets

Blackstone Labs SST-1: IGF is a highly specialized hormone-support style tablet formula built around a single disclosed active: 22.25mcg of IGF-1 (Insulin-Like Growth Factor-1) sourced from NXP-GF whey protein isolate per 4-tablet serving. That makes this a very different product from mainstream sports nutrition formulas loaded with pumps, stimulants, or recovery aminos. The formulation philosophy here is narrow and specific: deliver a small amount of IGF-1-containing whey-derived material in a tablet format, supported by a delivery-oriented excipient system that includes phosphatidylcholine and hydroxy propyl beta-cyclodextrin (HPBCD).

IGF-1 is a peptide growth factor that sits downstream of growth hormone signaling and is closely associated with tissue growth, repair signaling, nutrient partitioning, and anabolic physiology. In the body, endogenous IGF-1 is primarily produced by the liver in response to growth hormone, then acts through IGF-1 receptors to influence cell growth, protein synthesis signaling, and recovery-related processes. That physiology is real and well established. The critical nuance is delivery and dose context. The evidence tier for oral supplemental IGF-1 in this form is limited, and the 22.25mcg dose here is very small compared with the way IGF-1 is discussed in medical or pharmacologic contexts. In other words, this formula is positioned around a biologically meaningful pathway, but the research base supporting robust performance or physique outcomes from orally supplied whey-derived IGF-1 at this dose is not strong.

That honesty matters. The strength of SST-1: IGF is not clinical-dose certainty; it is full label transparency. There is no proprietary blend hiding the active amount. You know exactly what you are getting: one active, one stated dose, one source. In a category where products often imply hormonal effects while obscuring inputs, that disclosure is a real advantage. The supporting non-active ingredients also suggest formulation intent. Phosphatidylcholine is commonly used in lipid-based delivery systems, while HPBCD is frequently used to improve compound handling and inclusion characteristics in oral formulas. They do not turn this into pharmaceutical-grade delivery technology, but they show this is more than a loose powder compressed into a tablet.

From a synergy standpoint, the most relevant synergy is not inside the formula but around it. The ingredient knowledge base notes that endogenous IGF-1 is meaningfully influenced by upstream inputs like vitamin D status and growth hormone signaling. That means SST-1: IGF makes the most sense in a broader recovery stack that prioritizes sleep, protein sufficiency, resistance training, and foundational micronutrient support rather than being viewed as a standalone driver of dramatic change.

What should you expect? Day 1 is unlikely to feel acute or dramatic. This is not caffeine, citrulline, or beta-alanine. There is no immediate rush, pump, or stimulant signature. Over 2-4 weeks, users who choose this product are typically looking for subtle support within a disciplined training and recovery plan, not a highly perceptible sensation. The key takeaway: SST-1: IGF is a transparent, niche formula centered on a limited-evidence growth factor ingredient, best used by informed customers who understand both the pathway and the limitations.